These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 2099233)
1. [Europe 1993 and drugs]. Reuse J Bull Mem Acad R Med Belg; 1990; 145(8-9):341-9; discussion 349-50. PubMed ID: 2099233 [No Abstract] [Full Text] [Related]
2. [The EEC creates a European Medical Product Agency]. Johnson K Lakartidningen; 1993 Oct; 90(40):3395. PubMed ID: 8231477 [No Abstract] [Full Text] [Related]
3. The International Conference on Harmonization common technical document--global submission format? Molzon JA Food Drug Law J; 2005; 60(3):447-51. PubMed ID: 16304749 [No Abstract] [Full Text] [Related]
4. The shape of European business in 2003. Wagner M Med Device Technol; 2002 Dec; 13(10):8-10. PubMed ID: 12575520 [No Abstract] [Full Text] [Related]
6. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role]. Ainsworth MA Ugeskr Laeger; 2003 Apr; 165(16):1648-9. PubMed ID: 12756819 [TBL] [Abstract][Full Text] [Related]
7. Counterfeiting and piracy of pharmaceuticals. Grackin A IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698 [No Abstract] [Full Text] [Related]
8. [Mutual recognition: experiences and problems in various countries]. Van den Eede C Tijdschr Diergeneeskd; 1998 Jan; 123(2):54-6. PubMed ID: 9537076 [No Abstract] [Full Text] [Related]
9. Drugs firms fight biowar curbs. Bond M New Sci; 1997 Mar; 153(2072):8. PubMed ID: 11656632 [No Abstract] [Full Text] [Related]
10. The end of the beginning? Nat Biotechnol; 2006 Apr; 24(4):367. PubMed ID: 16601702 [No Abstract] [Full Text] [Related]
12. ISO 9000. Policy implications for FDA. Taking the pulse of increasing global use of the ISO series of uniform quality standards by FDA regulated industries. Schwemer WL; Lynch MA J Parenter Sci Technol; 1993; 47(3):101-18. PubMed ID: 8360802 [No Abstract] [Full Text] [Related]
14. [European drug market--dream or nightmare?]. Nord Med; 1974 Jan; 89(1):6-8. PubMed ID: 4819431 [No Abstract] [Full Text] [Related]
15. Europe reconsidering DTCA. Meek C CMAJ; 2007 May; 176(10):1405. PubMed ID: 17485687 [No Abstract] [Full Text] [Related]
16. [Veterinary Drug 'what'? Various marginal notes by an 'industrial veterinarian']. Hoftijzer J Tijdschr Diergeneeskd; 1987 Apr; 112(8):481-5. PubMed ID: 3576584 [TBL] [Abstract][Full Text] [Related]
17. [The "responsible pharmacist" in Europe: is there a French exception?]. Chalchat B Ann Pharm Fr; 2002 Sep; 60(5):352-5. PubMed ID: 12378147 [No Abstract] [Full Text] [Related]
18. Pharmacovigilance: an opportunity for the European Commission to put patients' interests first. Prescrire Int; 2010 Jun; 19(107):141. PubMed ID: 20738052 [No Abstract] [Full Text] [Related]
19. The challenges of globalization in pharmaceutical law--is an international drug approval system modeled after the European system worth considering? Purnhagen KP Food Drug Law J; 2008; 63(3):623-45. PubMed ID: 19031663 [No Abstract] [Full Text] [Related]
20. A clarification on global access to drugs. Rys A Science; 2007 Feb; 315(5814):939-40. PubMed ID: 17303736 [No Abstract] [Full Text] [Related] [Next] [New Search]